Search Results - "Taniwaki, Masaya"
-
1
Durvalumab-induced Severe Gastritis
Published in Internal Medicine (15-07-2022)Get full text
Journal Article -
2
Small Cell Lung Cancer with Bizarre Radiographic Findings
Published in Internal Medicine (01-12-2018)Get full text
Journal Article -
3
Intravascular Large B-cell Lymphoma with a Pulmonary [18F]-Fluorodeoxyglucose Uptake
Published in Internal Medicine (01-09-2018)Get full text
Journal Article -
4
Activation of KIF4A as a Prognostic Biomarker and Therapeutic Target for Lung Cancer
Published in Clinical cancer research (15-11-2007)“…Purpose and Experimental Design: To identify molecules that might be useful as diagnostic/prognostic biomarkers and as targets for the development of new…”
Get full text
Journal Article -
5
Organizing pneumonia in a carrier of human T-cell lymphotropic virus type-1
Published in Annals of thoracic medicine (01-01-2020)“…Human T-cell lymphotropic virus type-1 (HTLV-1)-associated bronchioloalveolar disorders (HABAs) are pulmonary disorders with various interstitial lung disease…”
Get full text
Journal Article -
6
A Rare Combination of Dermatomyositis, Interstitial Pneumonia, and Lung Cancer in a Patient Treated with Immunosuppressive Therapy and Chemotherapy
Published in Internal Medicine (01-01-2018)“…We herein report the rare case of co-occurring dermatomyositis (DM), interstitial pneumonia (IP), and lung cancer in a 59-year-old man. Computed tomography…”
Get full text
Journal Article -
7
Gene expression profiling of idiopathic interstitial pneumonias (IIPs): identification of potential diagnostic markers and therapeutic targets
Published in BMC medical genetics (18-08-2017)“…Chronic fibrosing idiopathic interstitial pneumonia (IIP) is characterized by alveolar epithelial damage, activation of fibroblast proliferation, and loss of…”
Get full text
Journal Article -
8
Pericardial Effusion With Tamponade in Lung Cancer Patients During Treatment With Nivolumab: A Report of Two Cases
Published in Frontiers in oncology (22-01-2019)“…Nivolumab is an immune checkpoint inhibitor (ICI) that has shown efficacy for treating non-small cell lung cancer and has become a standard therapy for…”
Get full text
Journal Article -
9
Efficacy of erlotinib and its effects on the quality of life of older patients with epidermal growth factor receptor‐mutant non‐small cell lung cancer: A prospective, multicenter, dose‐modification study
Published in Geriatrics & gerontology international (01-10-2021)“…Aim Gefitinib and erlotinib are efficacious and safe for older patients with epidermal growth factor receptor‐mutant non‐small cell lung cancer. However,…”
Get full text
Journal Article -
10
Atezolizumab-induced Sclerosing Cholangitis in a patient with lung cancer: A case report
Published in Cancer treatment and research communications (2021)“…•Several immune-related adverse events including liver injury have been reported to be associated with immune checkpoint inhibitor (ICI) therapy; however,…”
Get full text
Journal Article -
11
Multiple patchy pulmonary consolidation in granulomatosis with polyangiitis
Published in Respirology case reports (01-10-2020)“…Key message Multiple patchy pulmonary consolidations that are unresponsive to antibiotics and/or exist at peri‐bronchial sites and bloody bronchoalveolar…”
Get full text
Journal Article -
12
Characterization of SEZ6L2 cell‐surface protein as a novel prognostic marker for lung cancer
Published in Cancer science (01-08-2006)“…To identify molecules that might serve as biomarkers or targets for development of novel molecular therapies, we have been screening genes encoding…”
Get full text
Journal Article -
13
Pulmonary cryptococcosis in a ruxolitinib-treated patient with primary myelofibrosis
Published in Respiratory medicine case reports (01-01-2017)“…We present the case of a 79-year-old man who showed multiple pulmonary nodules on chest computed tomography (CT) after being treated for 6 months with…”
Get full text
Journal Article -
14
Smoldering adult T-cell leukemia complicated with pneumocystis pneumonia: A case report
Published in Respiratory medicine case reports (01-01-2021)“…Adult T-cell leukemia (ATL) is a tumor of CD4-positive T cells that accompanies an infection by human T-cell lymphotropic virus (HTLV-I). ATL is classified…”
Get full text
Journal Article -
15
First-Line Treatment with Carboplatin plus nab-Paclitaxel and Maintenance Monotherapy with nab-Paclitaxel for a Thymic Carcinoma: A Case Report
Published in Case reports in oncology (23-06-2017)“…Thymic carcinomas are rare malignant tumors, located in the anterior mediastinum. For the treatment of these carcinomas, several chemotherapy regimens have…”
Get full text
Journal Article -
16
Nivolumab Therapy for Synchronous ALK-Positive Lung Cancer and Gastric Cancer
Published in Case reports in oncology (24-04-2017)“…Nivolumab is an immune checkpoint inhibitor with demonstrated efficacy against several malignant tumors. Alterations in driver oncogenes such as EGFR and ALK…”
Get full text
Journal Article -
17
Effectiveness of Nivolumab in Large-Cell Neuroendocrine Carcinoma of the Lung - A Report of Two Cases
Published in Gan to kagaku ryoho (01-01-2017)“…The anti-programmed death-1 antibody nivolumab is an important treatment option for non-small-cell lung carcinoma.However, its effectiveness for large-cell…”
Get more information
Journal Article -
18
Pulmonary cryptococcosis mimicking lung cancer
Published in The Lancet infectious diseases (01-09-2019)Get full text
Journal Article -
19
Standard antifungal therapy for pulmonary cryptococcosis to improve prognosis – Authors' reply
Published in The Lancet infectious diseases (01-12-2019)Get full text
Journal Article -
20
Durvalumab-induced Severe Gastritis
Published in Internal Medicine (2022)Get full text
Journal Article